| |
|
No Identified Association Between Glecaprevir/Pibrentasvir Use and Risk of Hepatic Decompensation in HCV-Infected Patients With Compensated Cirrhosis at Baseline: An Active Comparator Cohort Study
|
| |
| |
Hep Dart 2019, December 8-12, 2019, Kauai, Hawaii
Reported by Jules Levin
Lani R Wegrzyn1,2, Carrie Huisingh1,2, Ariel Porcalla2, Lino Rodrigues3, Margaret Burroughs3, Meenal Patwardhan2, Andrew Campbell3, Ryan D Kilpatrick1,21AbbVie Global Epidemiology, North Chicago, Illinois, United States; 2AbbVie Pharmacovigilance and Patient Safety, North Chicago, Illinois, United States; 3AbbVie Clinical Development, North Chicago, Illinois, United States
| |
| |
| |
|
|
|
